Escalon Medical Corp.
ESMC
$0.208
$0.000.00%
| Weiss Ratings | ESMC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C- | |||
| Rating Factors | ESMC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ESMC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.20 | |||
| Price History | ESMC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 18.86% | |||
| 30-Day Total Return | 34.19% | |||
| 60-Day Total Return | 30.00% | |||
| 90-Day Total Return | 38.67% | |||
| Year to Date Total Return | 71.48% | |||
| 1-Year Total Return | -16.13% | |||
| 2-Year Total Return | 217.07% | |||
| 3-Year Total Return | 125.84% | |||
| 5-Year Total Return | 38.48% | |||
| 52-Week High % Change | -16.13% | |||
| 52-Week Low % Change | 96.60% | |||
| Price | ESMC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.25 | |||
| 52-Week Low Price | $0.11 | |||
| 52-Week Low Price (Date) | Jul 22, 2024 | |||
| 52-Week High Price (Date) | Mar 28, 2024 | |||
| Valuation | ESMC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.54M | |||
| Enterprise Value | 2.00M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -102.30% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.24 | |||
| Price/Book (Q) | 1.12 | |||
| Enterprise Value/Revenue (TTM) | 0.16 | |||
| Price | $0.21 | |||
| Enterprise Value/EBITDA (TTM) | 7.85 | |||
| Enterprise Value/EBIT | 9.48 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ESMC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 14.08M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ESMC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 610 688 6830 | |||
| Address | 435 Devon Park Drive Wayne, PA 19087 | |||
| Website | www.escalonmedical.com | |||
| Country | United States | |||
| Year Founded | 1987 | |||
| Profitability | ESMC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 1.73% | |||
| Profit Margin | 1.52% | |||
| Management Effectiveness | ESMC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.86% | |||
| Return on Equity | 9.64% | |||
| Income Statement | ESMC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 12.17M | |||
| Total Revenue (TTM) | 12.17M | |||
| Revenue Per Share | $0.86 | |||
| Gross Profit (TTM) | 5.38M | |||
| EBITDA (TTM) | 254.10K | |||
| EBIT (TTM) | 210.60K | |||
| Net Income (TTM) | 186.10K | |||
| Net Income Avl. to Common (TTM) | 186.10K | |||
| Total Revenue Growth (Q YOY) | 12.25% | |||
| Earnings Growth (Q YOY) | 422.41% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 238.33% | |||
| Balance Sheet | ESMC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 520.60K | |||
| Cash Per Share (Q) | $0.04 | |||
| Total Current Assets (Q) | 4.30M | |||
| Total Preferred Equity (Q) | 0.65 | |||
| Total Equity (Q) | 2.02M | |||
| Current Ratio (Q) | 1.946 | |||
| Book Value Per Share (Q) | $0.19 | |||
| Total Assets (Q) | 4.49M | |||
| Total Current Liabilities (Q) | 2.21M | |||
| Total Debt (Q) | 329.10K | |||
| Total Liabilities (Q) | 2.46M | |||
| Total Common Equity (Q) | 1.38M | |||
| Cash Flow | ESMC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 0.00 | |||
| Cash from Financing (TTM) | -39.20K | |||
| Net Change in Cash (TTM) | 130.30K | |||
| Levered Free Cash Flow (TTM) | 131.30K | |||
| Cash from Operations (TTM) | 169.50K | |||
